Novo Nordisk A/S | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (92)

Latest Posts

About This Stock More About This Stock
5 Diverse Medical Stocks To Buy For 2023 And Beyond
Article By: Zacks Investment Research
Saturday, April 8, 2023 11:46 AM EDT
Healthcare will always be essential to society, making many health companies viable investments for growth. A look at the five top-rated stocks that investors may want to consider buying for 2023 and beyond.
In this article: HUM, NVO, CHGCY, HZNP, CSLLY
Chart Of The Day: Novo Nordisk - All Time High
Article By: Jim Van Meerten
Thursday, March 23, 2023 11:00 AM EDT
Revenue is expected to grow 17.80% this year and another 13.50% next year. Earnings are estimated to increase by 32.70% this year and an additional 10.90% next year.
In this article: NVO
Novo Nordisk: Big Gains In Diabetes And Obesity Care
Article By:
Saturday, February 25, 2023 2:40 PM EDT
Danish pharmaceutical giant Novo Nordisk released its fourth quarter results, reporting $7.1 billion in revenues, up 22% year-over-year compared to $5.8 billion a year ago. With its diabetes and obesity care growing, how is it set to benefit?
In this article: NVO
Novo Nordisk: Impulsive Sequence Favors Upside & Remain Supported
Article By: Elliottwave Forecast
Sunday, February 19, 2023 3:50 AM EDT
Novo Nordisk A/S, a healthcare company engages in the research, development, manufacture and marketing of the pharmaceutical products worldwide.
In this article: NVO
Lose Weight, Grow Your Portfolio
Article By: Tony Daltorio
Wednesday, December 21, 2022 8:50 AM EDT
Novo Nordisk is set to become a major force in the weight loss market, thanks to its drug, Wegovy.
In this article: NVO

Latest Tweets for $NVO

No tweets yet!